Focal therapy offers middle ground for some prostate cancer patients




For men with low-risk prostate cancer, focal laser ablation treats just the diseased portion of the prostate rather than the entire gland. A phase 1 trial found it was safe. None of the nine men in the study had a significant side effect. Seven of the nine patients had no evidence of disease six months later.

Fuente : http://www.eurekalert.org/pub_releases/2013-03/uoc...

Martes, 5 de Marzo 2013
Jueves, 1 de Enero 1970
1

1 1
Otros artículos de esta sección